Drug Shortage Report for NEURONTIN
| Report ID | 27757 |
| Drug Identification Number | 02084287 |
| Brand name | NEURONTIN CAP 400MG |
| Common or Proper name | NEURONTIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 capsules |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-12-19 |
| Estimated end date | |
| Actual end date | 2018-02-07 |
| Shortage status | Resolved |
| Updated date | 2018-02-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2018-02-08 | English | Compare |
| v11 | 2018-02-07 | French | Compare |
| v10 | 2018-02-07 | English | Compare |
| v9 | 2018-01-19 | French | Compare |
| v8 | 2018-01-19 | English | Compare |
| v7 | 2017-12-20 | French | Compare |
| v6 | 2017-12-20 | English | Compare |
| v5 | 2017-12-18 | French | Compare |
| v4 | 2017-12-18 | English | Compare |
| v3 | 2017-11-01 | French | Compare |
| v2 | 2017-11-01 | English | Compare |
| v1 | 2017-11-01 | English | Compare |
Showing 1 to 12 of 12